The latest price target for Healthcare Realty Trust (NYSE:HR) was reported by Wedbush on January 2, 2025. The analyst firm set a price target for $16.00 expecting HR to fall to within 12 months (a possible -2.91% downside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for Healthcare Realty Trust (NYSE:HR) was provided by Wedbush, and Healthcare Realty Trust downgraded their underperform rating.

The last upgrade for Healthcare Realty Trust Inc happened on October 24, 2023 when BTIG raised their price target to $17. BTIG previously had a neutral for Healthcare Realty Trust Inc.

The last downgrade for Healthcare Realty Trust Inc happened on January 2, 2025 when Wedbush changed their price target from $18 to $16 for Healthcare Realty Trust Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on January 2, 2025 so you should expect the next rating to be made available sometime around January 2, 2026.

While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a downgraded with a price target of $18.00 to $16.00. The current price Healthcare Realty Trust (HR) is trading at is $16.48, which is out of the analyst’s predicted range.